# VYOME HOLDINGS, INC. (HIND) · Edgar & Edgarette company card

> Vyome Holdings (HIND) saw revenue fall 96.0% in FY2025 to $0 million, operating margin -3269% against a -3.8% median for pharmaceutical preparations, equity 57.9% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1427570 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/HIND) · [JSON](https://www.pops4.com/boards/company/HIND.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $319,714 |
| Revenue growth, 1 year | -96.0% |
| Revenue growth per year | -60.8% |
| Operating margin | -3269.4% (prior year -12.6%) |
| Net margin | -3277.2% |
| Operating cash flow | −$4M |
| Capital spending | — |
| Free cash flow | — |
| Cash | $5M |
| Long-term debt | — |
| Total assets | $6M |
| Total equity | $4M |
| Equity ÷ assets | 57.9% |
| Return on equity | -278.5% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -50.57 (distress zone)
- Piotroski F: 4 of 9 (middling)
- Beneish M: -17.5 (below the −1.78 line)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative (-$3.7M in FY2025); operating loss: a margin of -3269.4% in FY2025; revenue is hard to predict: its 80% range is ±76%

## Edgarette's reading

Exposure: revenue $320K (FY2025). Experience: revenue down 96.0% on the year, down 60.8% a year over 4 years; operating margin -3269.4%, down from -12.6%. Soundness: equity 57.9% of assets, return on equity -278.5%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $20K and $146K next year (method v4.1: its own 5-year record of growth weighed at 57% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $18K to $168K. A statistical range, not company guidance. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): operating margin -3269.4% against a -3.8% median; growth -96.0% against 13.7%.

Range logged 2026-09-24, receipt d8db47d3a29df876, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 1, latest 2026-08-28 ([filing](https://www.sec.gov/Archives/edgar/data/1427570/000121390026095093/0001213900-26-095093-index.htm))

## Recent filings

- 8-K · filed 2026-08-28 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1427570/000121390026095093/0001213900-26-095093-index.htm)
- 8-K · filed 2026-08-25 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1427570/000121390026093512/0001213900-26-093512-index.htm)
- 10-Q · filed 2026-08-12 · [filing](https://www.sec.gov/Archives/edgar/data/1427570/000121390026088402/0001213900-26-088402-index.htm)
- 8-K · filed 2026-05-29 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1427570/000121390026062458/0001213900-26-062458-index.htm)
- 10-Q · filed 2026-05-12 · [filing](https://www.sec.gov/Archives/edgar/data/1427570/000121390026055058/0001213900-26-055058-index.htm)
- 8-K · filed 2026-04-29 · 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1427570/000121390026049312/0001213900-26-049312-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001427570.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1427570

## Cite

POPS4, Edgar & Edgarette: VYOME HOLDINGS, INC. (HIND) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/HIND. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.